6th Circuit Upholds Rulings in Favor of Drug Makers in Reglan/Metoclopramide Actions

CINCINNATI — Strict liability, negligence and warranty claims brought against the makers of generic Reglan are federally preempted because they sound in failure to warn and therefore must be dismissed, the 6th Circuit U.S. Court of Appeals has affirmed.

On Dec. 2, the appellate court also upheld a grant of summary judgment to the Reglan manufacturers, finding that under Tennessee law they cannot be held liable for products that were not ingested by the plaintiffs.

Plaintiffs in these seven consolidated cases allege they developed tardive dyskinesia as a result of their ingestion of generic Reglan (metoclopramide). They sued Reglan makers …